Medpace Holdings (MEDP) Receivables (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Receivables data on file, last reported at $463.1 million in Q2 2026.

• Quarterly Receivables rose 20.61% year-over-year to $463.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $463.1 million (up 20.61% YoY) and the FY2025 annual result came in at $427.4 million, up 41.63% from the prior year.
• Receivables rose to $463.1 million in Q2 2026, from $418.8 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $463.1 million in Q2 2026 to a low of $264.4 million in Q1 2022.
• A 5-year average of $331.8 million and a median of $308.4 million in 2023 frame the typical range for Receivables.
• Annual changes were most pronounced in 2024 — Receivables fell 5.95% — and 2025, when it jumped 41.63%.
• Tracing MEDP's Receivables over 5 years: stood at $293.8 million in 2022, then advanced by 9.21% to $320.9 million in 2023, then retreated by 5.95% to $301.8 million in 2024, then soared by 41.63% to $427.4 million in 2025, then gained by 8.34% to $463.1 million in 2026.
• The last three Receivables figures came in at $463.1 million (Q2 2026), $418.8 million (Q1 2026), and $427.4 million (Q4 2025), per Business Quant data.